Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
25%(1 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits

NCT01466751
completednot_applicable

A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan

NCT01616797
completednot_applicable

Use of a Novel Neuroplasticity-based Neurobehavioral Intervention for PTSD

NCT01694316
completednot_applicable

Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being

NCT01694303

Clinical Trials (4)

Showing 4 of 4 trials
NCT01466751Not Applicable

Neurobehavioral Intervention as a Novel Treatment Approach for Emotion-Regulatory Deficits

Completed
NCT01616797Not Applicable

A Novel Neurobehavioral Intervention for Emotion Regulation in Anxiety and Depression Across the Lifespan

Completed
NCT01694316Not Applicable

Use of a Novel Neuroplasticity-based Neurobehavioral Intervention for PTSD

Completed
NCT01694303Not Applicable

Computerized Interventions for College Students' Cognitive Functioning and Mental Well-being

Completed

All 4 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
4